 2022 Guidance Meeting Announcement

Centene anticipates that subsequent events and developments may cause its estimates to change. The company will invite sell-side analysts to participate in person in New York, and ask others to participate virtually in a 2022 guidance meeting to be held on December 10. Brent Layton has a conflict that could not be avoided, but he will join the call on future dates.

# Third Quarter Results

In the third quarter, Centene generated revenue of $32.4 billion, with a Health Benefit Ratio (HBR) of 88.1% and adjusted earnings per share of $1.26. The company's performance provides a strong foundation for its value creation plan and it remains committed to its margin goals.

# Product Line Performance

Centene's diversified enterprise has been able to manage through the volatility of COVID, pent-up demand, and resulting 2021 marketplace pressure. During the quarter, the company continued to build on its authorizations compared to January 2021, with its adjusted SG&A expense ratio being 8.6%. The company has an SG&A rate in the '30s on service fee revenue of approximately $1.4 billion, which has an approximate 30 basis point mathematical impact on its consolidated SG&A rate for